Breaking News

SpectronRx Receives Nuclear Materials License for New Indiana Facility

Indiana-based radiopharmaceutical CDMO expands nuclear pharmacy capabilities with second location.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

SpectronRx, a radiopharmaceutical contract development and manufacturing organization (CDMO), said that the U.S. Nuclear Regulatory Commission (NRC) has issued a Materials License for its new Indianapolis, IN headquarters. The license also expands SpectronRx’s roster of authorized nuclear pharmacists and authorized users. The news comes as SpectronRx continues to scale its early-stage development and commercialization services for leading pharmaceutical companies working to develop and deploy ra...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters